Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Statement of Cash Flows [Abstract]      
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 230,463 $ 207,918 $ 286,846
Restricted Cash 8,064 0 0
Operating activities:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 41,381 206,587 254,127
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of effect of acquisitions:      
Depreciation and amortization 62,819 52,628 50,661
Stock-based compensation expense (76) 3,304 (76,192)
Business combination bargain purchase, gain recognized 0 0 (130,880)
Non-cash debt and financing costs 4,173 1,872 2,467
Loss on early extinguishment of debt 0 15,946 486
Net (gain) loss on sales and disposals of assets 800 (1,000) (1,200)
Stock-based compensation expense 12,084 12,866 7,657
Pension and other post-retirement benefits 6,816 4,938 4,717
Change in deferred income taxes 24,329 (49,757) 564
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 19,710 1,660 (992)
Rent receivable 0 0 2,645
Other, net 70 (285) (680)
Changes in assets and liabilities, net of the effect of acquisitions:      
Accounts receivable 5,727 (8,910) 30,217
Inventories (3,394) (42,806) (13,827)
Prepaid expenses and other assets 3,962 (4,381) 4,330
Accounts payable (41,442) 7,650 (16,053)
Accrued income taxes (236) 1,046 1,317
Other operating liabilities 22,933 (70,627) 197
Net cash provided by (used in) operating activities 158,856 131,731 120,761
Investing activities:      
Capital expenditures (146,331) (146,056) (65,004)
Contributions to equity method investments (5,000) (4,000) (3,000)
Proceeds from Equity Method Investment, Distribution 433 776 2,745
Acquisitions, net of cash received 1,294 0 (163,985)
Proceeds from sale of discontinued operations     3,400
Proceeds from sale of assets 0 2,268 3,638
Payments for (Proceeds from) Hedge, Investing Activities 8,879 0 0
Net cash provided by (used in) investing activities (143,313) (147,012) 102,364
Financing activities:      
Payments of revolving line of credit 0 0 (33,881)
Proceeds from issuance of debt 0 284,924 334,978
Payment of long-term debt (26,862) (344,461) (365,938)
Proceeds from Issuance of Unsecured Debt 43,095 13,412 0
Proceeds from Hedge, Financing Activities 6,476 0 0
Payment for Debt Extinguishment or Debt Prepayment Cost 0 (3,234) 0
Debt issuance costs 0 (2,021) (5,002)
Cash flow hedge settlement (6,972) 0 0
Finance Lease, Principal Payments (1,447) 0 0
Proceeds from exercise of stock options 327 485 5,207
Proceeds from exercise of stock warrants 0 0 8,838
Payments of Ordinary Dividends, Common Stock (5,803) (5,762) 0
Net cash provided by (used in) financing activities 8,814 (56,657) (55,798)
Net increase (decrease) in cash, cash equivalents, and restricted cash 24,357 (71,938) 167,327
Effect of foreign currency fluctuations on cash (1,812) (6,990) 9,745
Cash, cash equivalents, and restricted cash at end of fiscal year 222,399 207,918 286,846
Supplemental Cash Flow Statement Information:      
Interest paid, net of capitalized interest 6,675 18,701 44,905
Income taxes paid 9,668 10,863 7,120
Increase Decrease in Capital Expenditures Incurred But Not Yet Paid $ 6,160 $ 18,029 $ 7,980